Quest Diagnostics (DGX)

EBITDA Margin

19.36%

Quarterly · Period ending:

DGX logo

DGX EBITDA Margin

Latest reported19.36%
DGX Quarterly EBITDA Margin (-38.95% → 19.36%)
High-resolution chart · PNG

DGX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Quest Diagnostics EBITDA Margin — Quarterly
Period endingEBITDA Margin
19.3559%
18.791%
19.4583%
19.4247%
21.5864%
18.4012%
19.3438%
19.2524%
19.9416%
18.2164%
17.1329%
19.6514%
20.0171%
18.0609%
11.1873%
19.9517%
18.9971%
22.7882%
23.5423%
28.5869%
37.451%
28.125%
29.8468%
31.7301%
21.1275%
13.4468%
23.5722%
20.2965%
20.0717%
18.0857%
15.6063%
20.3282%
20.0104%
18.259%
17.9236%
18.9539%
20.3809%
18.1675%
18.3235%
20.6366%
25.1312%
14.4928%
17.0903%
37.4468%
16.2078%
12.398%
18.3218%
17.5945%
18.5068%
16.6667%
19.9307%
42.9187%
20.2677%
17.2394%
18.9812%
20.7247%
21.604%
19.7788%
21.693%
21.0174%
20.8646%
5.7413%
20.1926%
21.3278%
22.9054%
20.85%
21.1231%
22.3809%
22.2926%
21.6935%
20.2673%
17.3511%
20.955%
15.7041%
21.502%
17.3163%
16.5986%
13.1614%
21.203%
18.498%
21.8947%
19.7876%
19.5827%
21.4175%
22.0832%
17.4244%
21.2821%
21.2605%
21.0273%
19.9045%
19.6335%
20.9668%
21.0628%
18.318%
17.4103%
18.1268%
18.0735%
16.7704%
15.6859%
15.7478%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.